Literature DB >> 2115082

Variation in severity of respiratory syncytial virus infections with subtype.

K M McConnochie1, C B Hall, E E Walsh, K J Roghmann.   

Abstract

Two major subtypes of respiratory syncytial virus have been identified. This study assessed the hypothesis that A-subtype infections were more severe than B-subtype infections among the 157 infants hospitalized in two hospitals in Rochester, N.Y., during two winters. Severity was measured both by specific clinical observations and by a severity index that was derived empirically. Among all subjects, several clinical observations suggested that A-subtype infections were more severe. For example, mechanical ventilation was required in 12.6% of those with A-subtype compared with 1.6% of those with B-subtype infection (relative risk = 7.88; p = 0.01). Among high-risk infants (infants with underlying conditions or age 3 months or less at admission), carbon dioxide tension greater than 45 mm Hg was found in 37.0% of those with A-subtype compared with 12.0% of those with B-subtype infection (relative risk = 3.08; p = 0.04). In discrete multivariate (logit) analysis, effects of subtype (odds ratio = 6.59; p less than 0.01) on severity remained after adjustment for other statistically significant effects of age less than 3 months, underlying condition, and premature birth. The finding that A-subtype infections were more severe might have important implications for vaccine development, studies of the virulence of respiratory syncytial virus, clinical management (e.g., selection for antiviral therapy), and long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115082     DOI: 10.1016/s0022-3476(05)82443-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  54 in total

1.  Group B strains of human respiratory syncytial virus in Saudi Arabia: molecular and phylogenetic analysis.

Authors:  Fahad N Almajhdi; Mohamed A Farrag; Haitham M Amer
Journal:  Virus Genes       Date:  2013-12-27       Impact factor: 2.332

2.  Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic.

Authors:  K J Henrickson; L L Savatski
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Identification of subgroups of bovine respiratory syncytial virus.

Authors:  J C Baker; E G Wilson; G L McKay; R J Stanek; W J Underwood; L F Velicer; M A Mufson
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Local variability in respiratory syncytial virus disease severity.

Authors:  A H Brandenburg; P Y Jeannet; H A Steensel-Moll; A Ott; P H Rothbarth; W Wunderli; S Suter; H J Neijens; A D Osterhaus; C A Siegrist
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

5. 

Authors:  François Freymuth; Geneviève Eugène; Jacques Brouard; Astrid Vabret; Joëlle Petitjean; Françoise Bonnin
Journal:  Ann Inst Pasteur Actual       Date:  2000-04-05

6. 

Authors:  G Dutau
Journal:  J Pediatr Pueric       Date:  2005-01-18

Review 7.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 8.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Human Respiratory Syncytial Virus Subtypes A and B Infection Among Children Attending Primary and Secondary Health Care Facilities in Ibadan, Nigeria.

Authors:  O Ogunsemowo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-03

10.  Distribution and seasonality of rhinovirus and other respiratory viruses in a cross-section of asthmatic children in Trinidad, West Indies.

Authors:  Jason Matthew; Lexley M Pinto Pereira; Tressa E Pappas; Cheri A Swenson; Kris A Grindle; Kathy A Roberg; Robert F Lemanske; Wai-Ming Lee; James E Gern
Journal:  Ital J Pediatr       Date:  2009-06-25       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.